We have collected information about In Vivo Delivery Of The Caveolin-1 Scaffolding Domain for you. Follow the links to find out details on In Vivo Delivery Of The Caveolin-1 Scaffolding Domain.
https://www.nature.com/articles/nm1200_1362
Dec 01, 2000 · Caveolin-1, the primary coat protein of caveolae, has been implicated as a regulator of signal transduction through binding of its “scaffolding domain” to key signaling molecules. However, the ...Author: Mariarosaria Bucci, Jean Philippe Gratton, Radu Daniel Rudic, Lisette Acevedo, Fiorentina Roviezzo, ...
https://www.ncbi.nlm.nih.gov/pubmed/11100121
In vivo delivery of the caveolin-1 scaffolding domain inhibits nitric oxide synthesis and reduces inflammation. Bucci M(1), Gratton JP, Rudic RD, Acevedo L, Roviezzo F, Cirino G, Sessa WC. Author information: (1)Department of Pharmacology, Boyer Center for Molecular Medicine, Yale University School of Medicine, New Haven, Connecticut 06536, USA.Author: Mariarosaria Bucci, Jean Philippe Gratton, Radu Daniel Rudic, Lisette Acevedo, Fiorentina Roviezzo, ...
https://www.researchgate.net/publication/232782023_In_vivo_delivery_of_the_caveolin-1_scaffolding_domain_inhibits_nitric_oxide_synthesis_and_reduces_inflammation
In vivo delivery of the caveolin-1 scaffolding domain inhibits nitric oxide synthesis and reduces inflammation Article (PDF Available) in Nature Medicine 6(12):1362-1367 · December 2000 with 228 ...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3840264/
Nov 15, 2013 · Caveolin-1 scaffolding domain promotes leukocyte adhesion by reduced basal endothelial nitric oxide-mediated ICAM-1 phosphorylation in rat mesenteric venules. ... In vivo delivery of the caveolin-1 scaffolding domain inhibits nitric oxide synthesis and reduces inflammation.Author: Sulei Xu, Xueping Zhou, Dong Yuan, Yanchun Xu, Pingnian He
https://www.academia.edu/15380746/In_vivo_delivery_of_the_caveolin-1_scaffolding_domain_inhibits_nitric_oxide_synthesis_and_reduces_inflammation
In vivo delivery of the caveolin-1 scaffolding domain inhibits nitric oxide synthesis and reduces inflammation
https://www.enzolifesciences.com/ALX-153-064/caveolin-1-scaffolding-domain-peptide/
Caveolin-1 scaffolding domain peptide - ALX-153-064. ... eNOS (NOS III) activity and cellular nitric oxide (NO) release in vitro and reduces inflammation and tumorigenesis in vivo. Caveolin-1 interacts with several lipid-modified signalling ligands, such as EGFR, eNOS, G-protein α-subunits, PKCα, H-Ras, and Src, via the C1-SD82-101 sequence ...
https://www.researchgate.net/profile/Giuseppe_Cirino/publication/232782023_In_vivo_delivery_of_the_caveolin-1_scaffolding_domain_inhibits_nitric_oxide_synthesis_and_reduces_inflammation/links/02e7e5348e15f7dcc2000000.pdf
In vivo delivery of the caveolin-1 scaffolding domain inhibits nitric oxide synthesis and reduces inflammation M ARIAROSARIA B UCCI 1,2 , J EAN -P HILIPPE G RATTON 1 …
https://core.ac.uk/display/55078817
In vivo delivery of the caveolin-1 scaffolding domain inhibits nitric oxide synthesis and reduces inflammation. ... and cholesterol transport. To directly address the importance of the caveolin scaffolding domain in vivo, we generated a chimeric peptide with a cellular internalization sequence fused to the caveolin-1 scaffolding domain (amino ...
https://www.physiology.org/doi/10.1152/ajplung.00295.2007
Caveolin-1 is a master regulator of collagen expression by cultured lung fibroblasts and of lung fibrosis in vivo. A peptide equivalent to the caveolin-1 scaffolding domain (CSD peptide) inhibits collagen and tenascin-C expression by normal lung fibroblasts (NLF) and fibroblasts from the fibrotic lungs of scleroderma patients (SLF).Author: Elena Tourkina, Mathieu Richard, Pal Gööz, Michael Bonner, Jaspreet Pannu, Russell Harley, Pascal N....
Searching for In Vivo Delivery Of The Caveolin-1 Scaffolding Domain?
You can just click the links above. The data is collected for you.
